KISPLYX

This brand name is authorized in Austria, Estonia, Spain, Finland, Ireland, Lithuania, Netherlands, Poland, Romania, United Kingdom

Active ingredients

The drug KISPLYX contains one active pharmaceutical ingredient (API):

1 Lenvatinib
UNII 3J78384F61 - LENVATINIB MESYLATE

Lenvatinib is a receptor tyrosine kinase (RTK) inhibitor that selectively inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors, in addition to other proangiogenic and oncogenic pathway-related RTKs including fibroblast growth factor (FGF) receptors, the platelet derived growth factor (PDGF) receptor PDGFRα, KIT, and RET. Lenvatinib has shown mainly antiangiogenic properties in vitro and in vivo, and direct inhibition of tumour growth was also observed in in vitro models.

Read about Lenvatinib

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
KISPLYX Hard capsule Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L01EX08 L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01EX Other protein kinase inhibitors
Discover more medicines within L01EX08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1728378, 1728389, 1821787, 1821798, 1821800, 1821811
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 1161128001, 1161128002
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 453579, 467073
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 335615, 335617
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1080867, 1080868, 1088910, 1088911, 1088912, 1088913
Country: NL Z-Index G-Standaard, PRK Identifier(s): 133256, 133299
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100377486, 100377492
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W68099001, W68099002, W68099003, W68100001, W68100002, W68100003

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.